Metropolitan Life Insurance Company (MetLife)’s Ispire Technology ISPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,137
Closed -$6.97K 1063
2024
Q1
$6.97K Hold
1,137
﹤0.01% 2220
2023
Q4
$13.8K Buy
+1,137
New +$11.6K ﹤0.01% 2064

Other funds holding ISPR

Metropolitan Life Insurance Company (MetLife)'s ISPR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ispire Technology (ISPR) in Q2 2024, closing a stake of 1,137 shares — an estimated $6.97K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ISPR in Q4 2023 and held it in 2 quarters. The position peaked at $13.8K in Q4 2023. 37 funds tracked by Wall St. Rank hold ISPR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ispire Technology position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,137 Ispire Technology shares in Q2 2024, an estimated $6.97K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ispire Technology in Q4 2023 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ispire Technology position peaked at $13.8K in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Ispire Technology as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.